Forstner Rosemarie, Thomassin-Naggara Isabelle, Cunha Teresa Margarida, Kinkel Karen, Masselli Gabriele, Kubik-Huch Rahel, Spencer John A, Rockall Andrea
Department of Radiology, Landeskliniken Salzburg, Paracelsus Medical University, Müllner Hauptstr. 48, A-5020, Salzburg, Austria.
Sorbonne Universités, UPMC Univ. Paris 06, Institut Universitaire de Cancérologie, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Tenon, Service de Radiologie, 54 avenue Gambetta, 75020, Paris, France.
Eur Radiol. 2017 Jun;27(6):2248-2257. doi: 10.1007/s00330-016-4600-3. Epub 2016 Oct 21.
An update of the 2010 published ESUR recommendations of MRI of the sonographically indeterminate adnexal mass integrating functional techniques is provided. An algorithmic approach using sagittal T2 and a set of transaxial T1 and T2WI allows categorization of adnexal masses in one of the following three types according to its predominant signal characteristics. T1 'bright' masses due to fat or blood content can be simply and effectively determined using a combination of T1W, T2W and FST1W imaging. When there is concern for a solid component within such a mass, it requires additional assessment as for a complex cystic or cystic-solid mass. For low T2 solid adnexal masses, DWI is now recommended. Such masses with low DWI signal on high b value image (e.g. > b 1000 s/mm) can be regarded as benign. Any other solid adnexal mass, displaying intermediate or high DWI signal, requires further assessment by contrast-enhanced (CE)T1W imaging, ideally with DCE MR, where a type 3 curve is highly predictive of malignancy. For complex cystic or cystic-solid masses, both DWI and CET1W-preferably DCE MRI-is recommended. Characteristic enhancement curves of solid components can discriminate between lesions that are highly likely malignant and highly likely benign.
• MRI is a useful complementary imaging technique for assessing sonographically indeterminate masses. • Categorization allows confident diagnosis in the majority of adnexal masses. • Type 3 contrast enhancement curve is a strong indicator of malignancy. • In sonographically indeterminate masses, complementary MRI assists in triaging patient management.
本文提供了2010年发布的欧洲泌尿生殖放射学会(ESUR)关于超声检查不确定附件包块的MRI检查建议的更新内容,其中整合了功能成像技术。采用矢状位T2加权像以及一组横轴位T1加权像和T2加权像的算法方法,可根据附件包块的主要信号特征将其分为以下三种类型之一。对于因脂肪或血液成分导致T1加权像呈“高信号”的包块,可通过T1加权像、T2加权像和脂肪抑制T1加权像的联合成像简单有效地进行判定。当怀疑此类包块内存在实性成分时,则需要像对复杂囊性或囊实性包块一样进行额外评估。对于T2加权像呈低信号的实性附件包块,现推荐采用扩散加权成像(DWI)。在高b值图像(如b>1000 s/mm²)上DWI信号较低的此类包块可被视为良性。任何其他实性附件包块,若显示中等或高DWI信号,则需要通过对比增强(CE)T1加权成像进一步评估,理想情况下采用动态对比增强磁共振成像(DCE MR),其中3型曲线对恶性肿瘤具有高度预测性。对于复杂囊性或囊实性包块,推荐同时采用DWI和CE T1加权成像——最好是DCE MRI。实性成分的特征性强化曲线可区分高度可能为恶性和高度可能为良性的病变。
• MRI是评估超声检查不确定包块的一种有用的补充成像技术。• 分类有助于对大多数附件包块做出可靠诊断。• 3型对比增强曲线是恶性肿瘤的有力指标。• 在超声检查不确定的包块中,补充性MRI有助于对患者管理进行分类。